179246-11-8

Basic information

• Product Name: 6-ACETOXY-4-CHLOROQUINAZOLINE
• Synonyms: 6-ACETOXY-4-CHLOROQUINAZOLINE;6-Quinazolinol, 4-chloro-, 6-acetate;4-Chloroquinazolin-6-yl acetate;4-Chloro-6-quinazolinyl acetate
• CAS NO: 179246-11-8
• Molecular Formula: C₁₀H₇ClN₂O₂
• Molecular Weight: 222.63
• Mol File: 179246-11-8.mol
• Article Data: 17

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-ACETOXY-4-CHLOROQUINAZOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-ACETOXY-4-CHLOROQUINAZOLINE(179246-11-8)
• EPA Substance Registry System: 6-ACETOXY-4-CHLOROQUINAZOLINE(179246-11-8)

Safety Data

• Hazardous Substances Data: 179246-11-8(Hazardous Substances Data)

Usage

General Description

6-Acetoxy-4-chloroquinazoline is a chemical compound with the molecular formula C10H8ClNO2. It is a chlorinated quinazoline derivative that contains an acetoxy group. 6-ACETOXY-4-CHLOROQUINAZOLINE is commonly used in the pharmaceutical industry for its potential medicinal properties. It has been studied for its anti-cancer, anti-inflammatory, and antimicrobial activities, with potential applications in drug development. The presence of both a chloro and acetoxy group in its structure suggests that 6-acetoxy-4-chloroquinazoline may have a wide range of biological activities, making it a promising candidate for further research and development in the field of medicinal chemistry.

Upstream product

• 16064-10-1 6-hydroxyquinazolin-4(3H)-one 
• 394-31-0 2-amino-5-hydroxybenzoic acid 
• 179688-15-4 4-hydroxyquinazoline-6-yl acetate 
• 16064-10-1 6-hydroxyquinazolin-4(3H)-one 
• 179688-15-4 3,4-dihydro-4-oxoquinazolin-6-yl acetate 

Downstream Products

• 184358-80-3 6-acetoxy-4-(3'-chloro-4'-fluoroanilino)quinazoline 
• 179248-74-9 acetic acid 4-(4-benzyloxy-phenylamino)-quinazolin-6-yl ester 
• 230955-64-3 acetic acid 4-(4-benzenesulfonyl-phenylamino)-quinazolin-6-yl ester 
• 1012057-30-5 4-(3-ethynylphenylamino)quinazolin-6-yl acetate 
• 230955-54-1 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl acetate 
• 230955-59-6 4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)quinazolin-6-yl acetate 
• 230955-60-9 4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)quinazolin-6-ol 
• 1012057-69-0 (R)-4-(1-phenylethylamino)quinazolin-6-yl acetate 
• 184358-81-4 4-(3'-chloro-4'-fluoroanilino)-6-hydroxyquinazoline 
• 230955-55-2 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-ol 
• 230955-72-3 N-{4-[4-(4-benzyloxy-phenylamino)-quinazolin-6-yloxy]-butyl}-2,2,2-trifluoro-N-(2-methanesulfonyl-ethyl)-acetamide 
• 230955-74-5 N-{4-[4-(4-benzenesulfonyl-phenylamino)-quinazolin-6-yloxy]-butyl}-2,2,2-trifluoro-N-(2-methanesulfonyl-ethyl)-acetamide 
• 848438-84-6 4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-6-ol 
• 848438-50-6 4-chloroquinazolin-6-ol 

Relevant articles and documents

HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and in Vitro and in Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability

HER2 kinase as a well-established target for breast cancer (BC) therapy is associated with aggressive clinical outcomes; thus, herein we present structural optimization for HER2-selective targeting. HER2 profiling of the developed derivatives demonstrated

Hetero-aromatic compound and its use in medicine

The invention provides a hetero-aromatic compound or a stereisomer, geometric isomer, tautomer, despinner, nitrogen oxide, hydrate, solvate, metabolite, metabolism precursor and pharmaceutically acceptable salt or prodrug thereof, which is used for treating proliferative diseases. The invention also discloses a pharmaceutical composition containing the compound and an application of the compound or pharmaceutical composition thereof in preparation of a medicine for treating proliferative diseases.

Kuikui zuo lin kind of target anti- tumor compound and its preparation method and application (by machine translation)

The present invention provides a chemical formula (I) indicated by the kuikui zuo lin kind of target anti- tumor compound and its preparation method, in particular to EGFR, HER - 2 and DNA multi-target anti- tumor compounds, also provides a method for preparing the same and in the application of the anti-tumor medicament. Studies show that the compounds of the invention have significant anti-tumor activity, metabolic stability relative to the reference substance EMB - 3 is improved notably. (by machine translation)